Skip to content

Upstream Bio, Inc. UPB Investment Proceeds

Investment Proceeds at other companies

Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
$23.92M+53.3%
Savara logo
SavaraSVRA
$13.13M-70.4%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$35M-74.5%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$25.51M
Theravance Biopharma logo
Theravance BiopharmaTBPH
$96M+194%
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
$17.5M-6.3%

Other financials

Income statement

See full
Revenue$1.0M+82.7%
Operating income-$43.6M-36.2%
Net income-$40.6M-48.8%
EPS (diluted)-$0.75-47.1%

Balance sheet

See full
Cash & equivalents$96.7M+35.6%
Total debt$1.1M-34.5%
Total equity$304.0M-31.8%
Total assets$318.1M-30.3%

Cash flow

See full
Operating cash flow-$47.9M-16.2%
CapEx$54.0K-70.8%
Free cash flow-$30.7M-55.0%

Valuation

See full
Market cap$346.11M-40.9%
Enterprise value$250.5M-51.4%
P/S104.2×-151×

Profitability

See full
Operating margin-5,176.5%+1,764pp
Net margin-4,719%+2,752pp

Returns & leverage

See full
Return on equity-41.8%
Debt / equity0.0×
Current ratio23.1×-24.3×

Where this comes from

Reported directly by Upstream Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments.

The official record: Upstream Bio, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Upstream Bio, Inc.'s investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Upstream Bio, Inc.'s investment proceeds?
Upstream Bio, Inc. (UPB) reported investment proceeds of $56.82M in Q1 2026.
How has Upstream Bio, Inc.'s investment proceeds changed year-over-year?
Upstream Bio, Inc.'s investment proceeds increased by 7.9% year-over-year, from $52.68M to $56.82M.
What does investment proceeds mean?
Cash received from sales, maturities, and redemptions of investment securities across all categories.